Lista de obras - Lionel Apetoh - Dominio Público Uruguay

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

artículo científico publicado en 2010

A novel dendritic cell subset involved in tumor immunosurveillance

artículo científico publicado en 2006

AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome.

artículo científico publicado en 2015

Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen.

artículo científico publicado en 2016

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

artículo científico publicado en 2009

An IL-27-Driven Transcriptional Network Identifies Regulators of IL-10 Expression across T Helper Cell Subsets

scientific article published on 01 November 2020

Anticancer effects of the microbiota: how the microbiome shapes the development of IL-9-producing T cells

artículo científico publicado en 2020

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer

artículo científico publicado en 2019

Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells

artículo científico publicado en 2013

CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer

artículo científico publicado en 2008

Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

artículo científico publicado en 2016

Calreticulin exposure dictates the immunogenicity of cancer cell death

artículo científico publicado en 2007

Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?

artículo científico publicado en 2019

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

artículo científico publicado en 2008

Cancer is not just a disease of a tissue: It is a host disease

artículo científico publicado en 2008

Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation

artículo científico publicado en 2015

Cell-Intrinsic Roles for Autophagy in Modulating CD4 T Cell Functions

artículo científico publicado en 2018

Cell-death-associated molecular patterns as determinants of cancer immunogenicity

artículo científico

Chemotherapy and immunomodulation: from immunogenic chemotherapies to novel therapeutic strategies

artículo científico publicado en 2013

Chemotherapy and radiotherapy: cryptic anticancer vaccines

artículo científico publicado en 2010

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

artículo científico publicado en 2015

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

artículo científico publicado en 2012

Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance

artículo científico publicado en 2019

Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?

artículo científico

Consensus guidelines for the detection of immunogenic cell death

artículo científico publicado en 2014

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

artículo científico publicado en 2015

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy

artículo científico publicado en 2011

Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?

artículo científico

Correction: Corrigendum: The receptor NLRP3 is a transcriptional regulator of TH2 differentiation

artículo científico publicado en 2015

Correction: Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway

artículo científico publicado en 2017

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

artículo científico publicado en 2019

Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth

artículo científico publicado en 2012

Danger signals: Chemotherapy enhancers?

artículo científico publicado en 2017

Desirable cell death during anticancer chemotherapy

artículo científico publicado en 2010

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

artículo científico publicado en 2016

Ecto-calreticulin in immunogenic chemotherapy

artículo científico publicado en 2007

Enhancing the anticancer effects of 5-fluorouracil: current challenges and future perspectives

artículo científico publicado en 2015

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

artículo científico publicado en 2016

FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial

artículo científico publicado en 2012

Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions

artículo científico publicado en 2019

HSP70 is a negative regulator of NLRP3 inflammasome activation

artículo científico publicado en 2019

Harnessing dendritic cells in cancer

artículo científico publicado en 2011

Human FOXP3 and cancer

artículo científico publicado en 2010

Human ectonucleotidase-expressing CD25(high) Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions

artículo científico publicado en 2015

IL-27-Induced Type 1 Regulatory T-Cells Produce Oxysterols that Constrain IL-10 Production.

artículo científico publicado en 2017

IRF8-dependent molecular complexes control the Th9 transcriptional program.

artículo científico publicado en 2017

Immune effects of 5-fluorouracil: Ambivalence matters

artículo científico publicado en 2013

Immunogenic cancer cell death: a key-lock paradigm

artículo científico publicado en 2008

Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells.

artículo científico publicado en 2007

Immunogenic death of colon cancer cells treated with oxaliplatin

artículo científico publicado en 2009

Immunogenicity of anthracyclines: moving towards more personalized medicine

artículo científico publicado en 2008

Immunological aspects of cancer chemotherapy

artículo científico publicado en 2008

Immunotherapeutic properties of chemotherapy

artículo científico publicado en 2017

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival

artículo científico publicado en 2011

Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27.

artículo científico publicado en 2011

Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα.

artículo científico publicado en 2016

La calréticuline détermine l’immunogénicité de la chimiothérapie et de la radiothérapie antitumorales

artículo científico publicado en 2007

Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic

artículo científico publicado en 2007

Links between innate and cognate tumor immunity

artículo científico publicado en 2007

Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells

artículo científico publicado en 2014

Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells

artículo científico publicado en 2010

Metallothioneins negatively regulate IL-27-induced type 1 regulatory T-cell differentiation.

artículo científico publicado en 2013

Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors

scientific article published on 19 July 2020

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

artículo científico publicado en 2015

Molecular characteristics of immunogenic cancer cell death.

artículo científico publicado en 2007

Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference

artículo científico publicado en 2007

Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies

artículo científico publicado en 2008

Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells.

artículo científico publicado en 2010

PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer ⬇️

artículo científico publicado en 2018

Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells

artículo científico publicado en 2008

Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway

artículo científico publicado en 2017

Prospective study of the evolution of blood lymphoid immune parameters during dacarbazine chemotherapy in metastatic and locally advanced melanoma patients

artículo científico publicado en 2014

Protection against malaria in mice is induced by blood stage-arresting histamine-releasing factor (HRF)-deficient parasites

artículo científico publicado en 2016

Protein kinase Cθ controls type 2 innate lymphoid cell and TH2 responses to house dust mite allergen

artículo científico publicado en 2016

Radiotherapy and immunogenic cell death

artículo científico publicado en 2015

Rationale for stimulator of interferon genes-targeted cancer immunotherapy

artículo científico publicado en 2017

Relation between bevacizumab dose intensity and high-grade glioma survival: a retrospective study in two large cohorts.

artículo científico publicado en 2011

Restoration of Antitumor Immunity Through Selective Inhibition of Myeloid Derived Suppressor Cells by Anticancer Therapies ⬇️

artículo científico publicado el 1 de julio de 2011

Role of myeloid-derived suppressor cells in tumor immunotherapy

artículo científico

SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth

artículo científico publicado en 2013

STING-dependent sensing of self-DNA drives silica-induced lung inflammation

artículo científico publicado en 2018

Selective autophagy restricts IL-9 secretion from TH9 cells: relevance in cancer growth

artículo científico publicado en 2017

Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells

artículo científico publicado en 2017

Signalling strength determines proapoptotic functions of STING.

artículo científico publicado en 2017

Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation

artículo científico publicado en 2017

Socs3 induction by PPARγ restrains cancer-promoting inflammation.

artículo científico publicado en 2013

Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression

artículo científico publicado en 2012

Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome.

artículo científico publicado en 2015

T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival

artículo científico publicado en 2011

TH9 cells in anti-tumor immunity

artículo científico publicado en 2016

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

artículo científico publicado en 2010

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

artículo científico publicado en 2011

Th9 cells: a new population of helper T cells

artículo científico publicado en 2016

Th9 cells: a novel CD4 T-cell subset in the immune war against cancer.

artículo científico publicado en 2015

The 6th R of Radiobiology: Reactivation of Anti-Tumor Immune Response

artículo científico publicado en 2019

The anticancer immune response: indispensable for therapeutic success?

artículo científico publicado en 2008

The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27.

artículo científico publicado en 2010

The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2.

artículo científico publicado en 2008

The immunosuppressive enzyme IL4I1 promotes FoxP3(+) regulatory T lymphocyte differentiation.

artículo científico publicado en 2015

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

artículo científico publicado en 2007

The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy

artículo científico

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

artículo científico publicado en 2013

The receptor NLRP3 is a transcriptional regulator of TH2 differentiation

scientific journal article

The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells

artículo científico publicado en 2014

The tumor microenvironment impairs Th1 IFNγ secretion through alternative splicing modifications of Irf1 pre-mRNA

artículo científico publicado en 2021

Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.

artículo científico publicado en 2010

Trial Watch: Adoptively transferred cells for anticancer immunotherapy

artículo científico publicado en 2017

Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity

scientific article published on 19 January 2010

Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients

artículo científico publicado en 2015

Type 1 regulatory T cells (Tr1) in autoimmunity

artículo científico publicado en 2011

Witch hunt against tumor cells enhanced by dendritic cells

artículo científico publicado en 2009

[Immunological aspects of anticancer chemotherapy]

scientific article published on 01 October 2008

Guía para el uso y la interpretación de ensayos para el seguimiento de la autofagia (4ª edición)

artículo científico

Lista de obras de Lionel Apetoh

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

A novel dendritic cell subset involved in tumor immunosurveillance

AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome.

Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen.

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

An IL-27-Driven Transcriptional Network Identifies Regulators of IL-10 Expression across T Helper Cell Subsets

Anticancer effects of the microbiota: how the microbiome shapes the development of IL-9-producing T cells

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells

CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer

Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

Calreticulin exposure dictates the immunogenicity of cancer cell death

Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

Cancer is not just a disease of a tissue: It is a host disease

Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation

Cell-Intrinsic Roles for Autophagy in Modulating CD4 T Cell Functions

Cell-death-associated molecular patterns as determinants of cancer immunogenicity

Chemotherapy and immunomodulation: from immunogenic chemotherapies to novel therapeutic strategies

Chemotherapy and radiotherapy: cryptic anticancer vaccines

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance

Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?

Consensus guidelines for the detection of immunogenic cell death

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy

Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?

Correction: Corrigendum: The receptor NLRP3 is a transcriptional regulator of TH2 differentiation

Correction: Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth

Danger signals: Chemotherapy enhancers?

Desirable cell death during anticancer chemotherapy

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

Ecto-calreticulin in immunogenic chemotherapy

Enhancing the anticancer effects of 5-fluorouracil: current challenges and future perspectives

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial

Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions

HSP70 is a negative regulator of NLRP3 inflammasome activation

Harnessing dendritic cells in cancer

Human FOXP3 and cancer

Human ectonucleotidase-expressing CD25(high) Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions

IL-27-Induced Type 1 Regulatory T-Cells Produce Oxysterols that Constrain IL-10 Production.

IRF8-dependent molecular complexes control the Th9 transcriptional program.

Immune effects of 5-fluorouracil: Ambivalence matters

Immunogenic cancer cell death: a key-lock paradigm

Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells.

Immunogenic death of colon cancer cells treated with oxaliplatin

Immunogenicity of anthracyclines: moving towards more personalized medicine

Immunological aspects of cancer chemotherapy

Immunotherapeutic properties of chemotherapy

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival

Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27.

Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα.

La calréticuline détermine l’immunogénicité de la chimiothérapie et de la radiothérapie antitumorales

Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic

Links between innate and cognate tumor immunity

Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells

Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells

Metallothioneins negatively regulate IL-27-induced type 1 regulatory T-cell differentiation.

Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Molecular characteristics of immunogenic cancer cell death.

Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference

Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies

Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells.

PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer ⬇️

Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells

Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway

Prospective study of the evolution of blood lymphoid immune parameters during dacarbazine chemotherapy in metastatic and locally advanced melanoma patients

Protection against malaria in mice is induced by blood stage-arresting histamine-releasing factor (HRF)-deficient parasites

Protein kinase Cθ controls type 2 innate lymphoid cell and TH2 responses to house dust mite allergen

Radiotherapy and immunogenic cell death

Rationale for stimulator of interferon genes-targeted cancer immunotherapy

Relation between bevacizumab dose intensity and high-grade glioma survival: a retrospective study in two large cohorts.

Restoration of Antitumor Immunity Through Selective Inhibition of Myeloid Derived Suppressor Cells by Anticancer Therapies ⬇️